Tami Crumley
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Coccidia and coccidiosis research, Synthesis and Biological Evaluation, Pharmacogenetics and Drug Metabolism, Veterinary medicine and infectious diseases, Asthma and respiratory diseases
Most-Cited Works
- → Purification and Molecular Characterization of cGMP-dependent Protein Kinase from Apicomplexan Parasites(2002)168 cited
- → Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin(2005)65 cited
- → Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents(2005)52 cited
- → A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment(2020)52 cited
- → Effects of lorazepam on fear-potentiated startle responses in man(2005)34 cited
- → The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers(2007)33 cited
- → Synthesis and SAR Studies of diarylpyrrole anticoccidial agents(2006)25 cited
- → Absorption, Metabolism, and Excretion of [14C]MK-0524, a Prostaglandin D2 Receptor Antagonist, in Humans(2007)25 cited
- → Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial(2022)24 cited
- → Serum Biochemical Changes after Laparoscopy May Be Indicators of Bladder Injury(2001)20 cited